Positive (Ph+) acute lymphoblastic leukemia (ALL) and more than 95% of chronic myelogenous leukemia (CML) patients have the BCR-ABL fusion gene. The gene discussed is BCR; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.